ABOUT SAPHNELO
SAPHNELO is an FDA-approved treatment that blocks type 1 interferon (IFN-1) activity, which plays a key role in how lupus attacks your body.
Talk to your healthcare provider about your treatment plan.
SAPHNELO is a prescription medicine used to treat adults with moderate to severe systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines.
SAPHNELO contains anifrolumab-fnia, which is in a group of medicines called monoclonal antibodies. Lupus is a disease of the immune system (the body’s system that fights infection). When given together with other medicines for lupus, SAPHNELO may help to reduce lupus disease activity more than other lupus medicines alone.
It is not known if SAPHNELO is effective in people with severe active lupus nephritis or central nervous system lupus. It is not known if SAPHNELO is safe and effective in children under 18 years of age.
SAPHNELO is a prescription medicine used to treat adults with moderate to severe systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines. When given together with other medicines for lupus, SAPHNELO may help to reduce your lupus disease activity more than other lupus medicines alone.
SAPHNELO is the only FDA-approved biologic for adults with moderate to severe lupus that’s shown to significantly lower steroid use.*,†,‡
Individual results may vary.
Talk to your healthcare provider before stopping or changing any medication, including steroids.
*Compared to other lupus medicines alone.
†A reduction in steroid use was seen in 4 studies, 1 of which was statistically significant.
‡Daily oral steroid dose was reduced to ≤7.5 mg per day during Weeks 8 to 40 and the dose was maintained from Weeks 40 to 52.
IV INFUSION
Before your infusion, it is important that you speak with your healthcare provider to know what to expect.
Download the discussion guide to help write down and prepare your questions for your healthcare team.
A healthcare professional will administer SAPHNELO to you through a needle placed in a vein (IV), such as a vein in your arm. It takes about 30 minutes to give you the full dose of SAPHNELO. SAPHNELO is usually given 1 time every 4 weeks. If you miss an appointment, call your healthcare provider as soon as possible to reschedule your appointment.
Talk to your healthcare provider if you have questions about how or where you will get your infusion.
SAPHNELO is usually given 1 time every 4 weeks.
It takes about 30 minutes to give you the full dose of SAPHNELO.
Ask your healthcare provider or infusion center team about the amount of time you can expect to be at your appointment.
Talk to your healthcare provider about what you should expect during an infusion.
You will likely be seated in a treatment chair as you receive your infusion. Your healthcare provider will give you SAPHNELO through a needle placed in a vein.
You may be able to do light activities during this time, such as reading, listening to music, or even using your electronic device. Check with your healthcare provider or infusion center team about their specific dos and don’ts and to learn more about services available to you.
No. Your SAPHNELO infusion treatment is not chemotherapy. SAPHNELO contains anifrolumab-fnia, which is in a group of medicines called monoclonal antibodies. SAPHNELO is a biologic therapy that targets type 1 interferon (IFN-1) activity, which plays a key role in how lupus attacks your body.
SELF-INJECTION
If you are having any problems with your SAPHNELO Pen, you can call SAPHNELO Supports at 1-866-SAPHNELO (1-866-727-4635) for assistance. Also, let your doctor know.
If you think your SAPHNELO Pen is damaged, you can call SAPHNELO Supports at 1-866-SAPHNELO (1-866-727-4635) for assistance. Also, let your doctor know.
Store your SAPHNELO Pen in a refrigerator between 36 °F to 46 °F (2 °C to 8 °C) in its original carton until you are ready to use it.
Do not freeze it, shake it, or expose it to heat. If you have a multipack of pens, be sure to store your remaining pens in the refrigerator.
To inject SAPHNELO, gather the following supplies:
The SAPHNELO Pen is administered once every week. Each SAPHNELO Pen contains 1 dose for one-time use only.
Your SAPHNELO Pen carton may contain 1 pen or 4 pens. Store your pens in their original carton to protect them from light in a refrigerator between 36 °F to 46 °F (2 °C to 8 °C) until ready to use. If needed, an unopened carton can be stored at room temperature between 68 °F to 77 °F (20 °C to 25 °C) for up to 7 days.
You or your caregiver can inject SAPHNELO in the following areas:
A caregiver may also inject into the upper arm.
Do not inject:
Always choose an injection site that is at least 1 inch (3 cm) away from where you last injected.
Click here to read the full Instructions for Use about how to self-administer your SAPHNELO Pen. Or, you can also watch a step-by-step instructional video here. Both will show you how to self-administer your SAPHNELO Pen.
To deliver a full dose, press and hold the SAPHNELO Pen down firmly for 15 seconds until the green plunger fills the viewing window.
Do not lift the pen up early. Wait to lift the pen until the green plunger has completely filled the viewing window.
Your doctor is the best source of information for your health and how to self-administer using your SAPHNELO Pen. If you would like additional information on how to inject your SAPHNELO Pen, you can call SAPHNELO Supports at 1-866-SAPHNELO (1-866-727-4635) for assistance.
Your SAPHNELO Pen or pre-filled syringe can be stored at room temperature (68 °F to 77 °F; 20 °C to 25 °C) for up to 7 days.
However, do not return the device to the refrigerator once it has reached room temperature.
If it has been longer than 7 days, dispose of the device in an FDA-cleared sharps disposal container and use a new one.
Yes, you can travel with your SAPHNELO Pen or pre-filled syringe, but follow these guidelines:
Plan ahead to ensure proper storage during your trip. If you have any concerns, talk to your healthcare provider or pharmacist.
Once you have completed the injection process, immediately dispose of the pen in an FDA-cleared sharps disposal container.
Do not throw away the pen in your household trash. Throw away the cap and other used supplies in your trash.
If you do not have an FDA-cleared sharps disposal container, you can:
– Has a tight-fitting, puncture-resistant lid
– Is upright and stable during use
– Is leak-resistant
– Is properly labeled to warn of hazardous waste inside
When the container is almost full, follow your community guidelines for proper disposal. For more information, visit www.fda.gov/safesharpsdisposal.
If you are currently receiving SAPHNELO as an IV (intravenous) infusion and are interested in switching to self-injections with the SAPHNELO Pen, talk to your healthcare provider.
Your healthcare provider will assess whether the SAPHNELO Pen is right for you and determine if switching to self-injections is appropriate for your treatment plan.
POSSIBLE SIDE EFFECTS AND SAFETY
Talk to your healthcare provider about possible side effects.
SAPHNELO may cause serious side effects, including:
These are not all the possible side effects of SAPHNELO.
Contact your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. SAPHNELO may affect the way other medicines work, and other medicines may affect how SAPHNELO works.
ABOUT SUPPORT & AFFORDABILITY
When you start a treatment, you may have questions about what’s next. The SAPHNELO Supports program is designed for people who have been prescribed SAPHNELO, and it was developed with the help of people who have lupus, as well as those who treat it.
When you sign up, you’ll get tips that may help you discuss questions with your doctor and educational resources, including a Welcome Kit, designed to help support you as you start treatment.
THANKS FOR REGISTERING!
THANKS FOR REGISTERING!
By completing this registration, I confirm that I am at least 18 years old, agree to receive information about SAPHNELO, and may receive information about other immunology medicines and services related to my condition which includes, but is not limited to, educational and promotional materials, special offers and services and for market research purposes, which includes contacting me to participate in focus groups, surveys or interviews. This may include AstraZeneca or a third party working on AstraZeneca's behalf contacting me by telephone, e-mail and text message regarding AstraZeneca Support Programs that may be of interest to me. Information provided by AstraZeneca does not take the place of talking to your healthcare provider about your treatment or condition. If you no longer want to receive health-related materials, call 1-800-236-9933. Please visit www.azprivacynotice.com to review our Privacy Notice.
By providing your phone number, you are opting in to receive updates and support messages from SAPHNELO. Text STOP to opt out. Text HELP for help. Message frequency will vary. Message and data rates may apply. For more information, visit Privacy Notice or Terms & Conditions.


Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. SAPHNELO may affect the way other medicines work, and other medicines may affect how SAPHNELO works.
SAPHNELO may cause serious side effects, including:
The most common side effects of SAPHNELO include:
These are not all the possible side effects of SAPHNELO. Call your healthcare provider for medical advice about side effects.
SAPHNELO is a prescription medicine used to treat adults with moderate to severe systemic lupus erythematosus (SLE or lupus) who are receiving other lupus medicines.
It is not known if SAPHNELO is effective in patients with severe active lupus nephritis or severe active central nervous system lupus. It is not known if SAPHNELO is safe and effective in patients under 18 years of age.
Please see full Prescribing Information, including Patient Information.
You may report side effects related to AstraZeneca productsOpens new window.